| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |
| mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |